Poster HTX - Immunosuppression, Therapeutics and Pharmacology

1083 - Giant-cell Myocarditis: A Case Series from the Perspective of a United Kingdom Cardiac Transplantation Centre

Presentation Number
1083
Presenter
Session Name
PO-3-HTX - Poster Session 3: Heart Transplantation
Date
Fri, Apr 13, 2018
Time
06:15 PM - 07:15 PM
Co-Authors

Previous Eposter
1140 - High Body Mass Index is a Risk Factor for Acute Cellular Rejection in Lung Transplant Recipients

Next Eposters
892 - Donor Right Ventricular Stroke Work Index (RVSWI) is a Poor Predictor of Primary Graft Dysfunction (PGD) After Heart Transplantation
1342 - Pseudomonas Aeruginosa Endophthalmitis and Meningitis in a Heart Transplant Patient
1343 - Post Lung Transplant Recurrence of Diffuse Panbronchiolitis; What Should Be Reconsidered? "Peri-Lung Transplant Management" or "Indication for Lung Transplant"?
1135 - Does ATG Induction Prevent Donor-specific Antibodies After Heart Transplantation?
1120 - Characterization of Vasoplegia Immediately After Heart Transplantation
909 - Multi-Drug Resistant Infection after Heart Transplantation: How Serious is This?
907 - Epstein-Barr Virus Mismatch (Donor+/Recipient-): Is Cancer the Only Risk?
1131 - Pathology Antibody-Mediated Rejection Plus Circulating Donor-Specific Antibodies Increase Development of Cardiac Allograft Vasculopathy After Heart Transplantation
1132 - The Clinical Impact of Early vs Late HLA Donor-Specific Antibody Development After Heart Transplantation
678 - The Technical Supervising System Organization of Patients Supported by HVAD in Poland